Trade TARA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Protara Therapeutics, Inc. (TARA) is trading at US$3.55, down 4.05% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$227.52M. Over the past 52 weeks, TARA has traded between US$3.45 and US$7.82. On Syfe you can trade TARA with $0 commission and add it to your watchlist.
| Previous close | US$3.70 |
|---|---|
| Market cap | US$227.52M |
| 52-week range | US$3.45 – US$7.82 |
| Volume | 3.95M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
Year: 2020
Protara Therapeutics CMO Leonardo Viana Nicacio Resigns
Jun 30, 11:30 AM · MT Newswires
Oppenheimer Adjusts Protara Therapeutics PT to $28 From $25, Maintains Outperform Rating
May 20, 12:26 PM · MT Newswires
Protara Therapeutics, Inc. (TARA) stock is trading at US$3.55, -4.05% from the previous close of US$3.70.
The market cap for Protara Therapeutics, Inc. (TARA) stock is approximately US$227.52M.
The 52-week high for Protara Therapeutics, Inc. (TARA) stock is US$7.82.
The 52-week low for Protara Therapeutics, Inc. (TARA) stock is US$3.45.
Protara Therapeutics, Inc. (TARA) does not currently pay a dividend.
Stay on top of TARA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
